SARS-CoV-2 & RSV Test
Is it RSV? Is it COVID-19? Actionable results in minutes.
Verify potential infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19.
Test benefits
- Microfluidic immunofluorescence assay
- Optimize patient and clinical flow - 1 sample, 2 results, 12 minutes
- Helps guide infection control measures quickly
- Sample Type: nasal swab
- Prepared sample can also be used with LumiraDx SARS-Cov-2 & Flu A/B Test*
- Easy to implement at point of care
- Time to result in as quick as 12 minutes
- No refrigeration storage required: room temperature storage (2-30°C)
- Minimal handling steps
- Small and portable Instrument
*Swab used must be validated for use with both tests - refer to swab technical bulletins
Test workflow
The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run.
The workflow process is comprised of a simple sample prep along with step-by-step guidance of the Instrument to report a patient result in under 12 minutes from sample application.
More info about the LumiraDx SARS-CoV-2 & RSV Test:
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.
BetterHealthExperiencesOutcomes
Supporting healthier lives, for individuals, communities and wider society.
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.